Earlier, we reported a predominance of CSCs/CSLCs in CR colon cancer cells that show increased ability to exclude drugs, and elevated expression of CSC markers such as CD44, CD166, CD133 and ALDH [38], [43], [56]. This evidence concerns the gene PROM1 and colonic neoplasm.